| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $23.3B | $24.0B | $24.5B | $25.1B | $26.0B | $6.3B | $6.0B | $6.1B |
| Cost of Revenue | $5.6B | $6.1B | $6.2B | $6.4B | $7.1B | $7.8B | $7.1B | $7.4B |
| Gross Profit | $14.5B | $14.4B | $14.3B | $14.2B | $14.0B | $3.1B | $3.1B | $2.9B |
| R&D Expense | $0.2B | $0.2B | $0.2B | $0.2B | $0.1B | $0.1B | $0.2B | $0.3B |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $9.9B | $11.2B | $11.5B | $11.9B | $11.6B | $10.9B | $10.3B | $9.1B |
| Net Income | $6.9B | $11.3B | $8.1B | $5.8B | $2.5B | $1.9B | $-1.8B | $1.3B |
| EPS (Basic) | $4.12 | $6.54 | $4.57 | $3.19 | $1.34 | $2.40 | $-0.97 | $0.67 |
| EPS (Diluted) | $4.12 | $6.54 | $4.57 | $3.19 | $1.34 | $2.40 | $-1.00 | $0.66 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $35.0B | $35.2B | $38.6B | $37.0B | $39.5B | $47.4B | $49.3B | $55.6B |
| Current Assets | $5.9B | $4.5B | $5.6B | $7.2B | $6.1B | $7.1B | $4.8B | $4.3B |
| Cash & Equivalents | $4.5B | $3.1B | $3.7B | $4.0B | $4.5B | $4.9B | $2.1B | $1.3B |
| Total Liabilities | $38.5B | $37.4B | $42.1B | $40.9B | $41.1B | $44.4B | $42.9B | $40.8B |
| Current Liabilities | $9.2B | $8.8B | $11.3B | $8.6B | $8.6B | $9.1B | $8.2B | $21.2B |
| Stockholders' Equity | $-3.5B | $-2.2B | $-3.5B | $-4.0B | $-1.6B | $2.8B | $6.2B | $14.8B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $9.3B | $8.8B | $9.3B | $8.3B | $8.4B | $8.4B | $7.8B | $8.4B |
| Investing Cash Flow | $-0.3B | $2.2B | $-1.3B | $0.8B | $1.2B | $-0.1B | $-2.4B | $-13.0B |
| Capital Expenditures | $0.2B | $0.1B | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B |
| Financing Cash Flow | $-7.6B | $-11.5B | $-8.4B | $-9.5B | $-10.0B | $-5.4B | $-4.7B | $4.7B |